Schedule 13G ownership disclosure

JASPER THERAPEUTICS INC

Voting Common Stock · CUSIP: 471871202

Event date: 2025-09-30

Filing-level shares
784,628
Percent of class
2.8%
  • Morgan Stanley

    Shares: 784,628 · Class: 2.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000572
Form type
SCHEDULE 13G/A
Filer
Jasper Therapeutics, Inc.
CIK
CIK 1788028
Filed
Nov 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub